Unlock instant, AI-driven research and patent intelligence for your innovation.

Anti-Inflammatory Humate Compositions and Methods of Use Thereof

a technology of humate and composition, which is applied in the direction of biocide, plant/algae/fungi/lichens, drug compositions, etc., can solve the problems of unsatisfactory patient needs, unfavorable non-experimental use, and large volume of liquid injection, so as to facilitate the delivery and increase the therapeutic effect.

Inactive Publication Date: 2006-10-19
TBNI
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a novel anti-inflammatory composition that includes humate, which is a natural substance found in soil. The humate can be used alone or in combination with other anti-inflammatory chemicals such as nonsteroidal anti-inflammatory drugs. The humate can be administered orally, topically, or through injection. The invention also includes a method of reducing inflammation in tissue by supplying a composition containing humate to the tissue. The humate acts as a carrier for the anti-inflammatory chemicals, facilitating their delivery to the tissue where they exert their therapeutic effect. The invention can be used to treat acute or chronic inflammation in humans."

Problems solved by technology

Unfortunately, direct intraperitoneal injection of large amounts of humate as described in Ye et al. is not practical for non-experimental purposes.
Even if the humate were solubilized in a very concentrated solution, this would require injection of an uncomfortably large volume of liquid.
Additionally, although humate is generally beneficial, overly large amounts of it are actually less effective as an anti-inflammatory agent than smaller amounts and may cause other, unknown health problems.
Despite this variety, there are still a number of patients whose needs are not well-met by the available range of anti-inflammatory drugs when administered in customary fashions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-Inflammatory Humate Compositions and Methods of Use Thereof
  • Anti-Inflammatory Humate Compositions and Methods of Use Thereof
  • Anti-Inflammatory Humate Compositions and Methods of Use Thereof

Examples

Experimental program
Comparison scheme
Effect test

example 1 -

Example 1-Composition of Menefee Humate®

[0031] Menefee Humate® is a humate of prehistoric origin found in the Menefee Geological Formation of northern N. Mex. Humate differs in its chemical and physical properties depending upon the source. Menefee Humate® is one of the world's highest quality humates for other known uses. Therefore, it was selected for use in the examples that follow.

[0032] Insoluble, granular Menefee Humate® is prepared by mining then screening the humate to a desired granule size. Because this process does not chemically alter the humate, it remains insoluble. The pH of the insoluble, granular Menefee Humate® is approximately 3.4 and its composition is approximately as follows:

Humic Acids50.00% Nitrogen (N)1.00%Potassium (K2O)Phosphate (P2O5)Calcium (Ca)1.04%Sulfur (S)0.18%Magnesium (Mg)0.14%Iron (Fe)0.30%Manganese (Mn)0.0004% Copper (Cu)0.0002% 

[0033] Other trace minerals may also be present in some samples.

[0034] Soluble Menefee Humate® is prepared by formi...

example 2 -

Example 2-Effects of Humate on Acute Inflammatory Response

[0036] Male Sprague Dawley rats weighing approximately 50 g were purchased from Harlan U.S. and housed in wire cages in the animal facility at Mercer University School of Pharmacy. The animals were given a short period of time to acclimate to the new environment and received powdered rat chow from Purina and water ad libitum. At the beginning of the experimental period, insoluble, granular Menefee Humate® was mixed with the powdered rat chow and placed in feeders. Rats received chow with either 0.1%, 0.5% or 1.0% insoluble, granular Menefee Humate® by weight. After 54 days of receiving humate in their food, the animals were injected in the subplantar region of the left hind paw with carrageenan (2%; 0.5 mg in 0.05 ml of saline). This substance produces an acute inflammation in the infected paw that increases over time and reaches a maximum approximately three hours post-injection. The contralateral paw received only saline an...

example 3 -

Example 3-Effect of Insoluble, Granular Menefee Humate® on Anti-Inflammatory Activity of Indomethacin

[0040] Male Sprague Dawley rats weighing approximately 50 g were purchased from Harlan U.S. and housed in wire cages in the animal facility at Mercer University School of Pharmacy. The animals were given a short period of time to acclimate to the new environment and received powdered rat chow from Purina and water ad libitum. At the beginning of the experimental period, the rats were divided into six groups of eight each. Control and indomethacin only groups received only powdered rat chow for the entire length of the experiment. For the four other groups, insoluble granular Menefee Humate® was mixed with the powdered rat chow and placed in feeders. Rats received chow with either 0.1%, 0.5% or 1.0% insoluble, granular Menefee Humate® by weight. After 37 days of receiving humate in their food, the animals weighed approximately 278 g, which in an appropriate size for inducing inflammat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
body weightaaaaaaaaaa
insolubleaaaaaaaaaa
solubleaaaaaaaaaa
Login to View More

Abstract

The disclosure relates to an anti-inflammatory composition containing humate, such as insoluble, granular, other insoluble, or soluble humate, particularly Menefee Humate®. The disclosure also includes other anti-inflammatory compositions containing humate and at least one additional anti-inflammatory agent such as indomethacin or another nonsteroidal anti-inflammatory drug. The disclosure includes a method of treating acute or chronic inflammation in an animal, including a human, by administering one of these compositions. A method of facilitating the therapeutic effect of a therapeutic drug in an animal by co-administering humate is also provided.

Description

PRIORITY CLAIM [0001] The present application is a continuation under 35 U.S.C. §120 of U.S. patent application Ser. No. 10 / 336,484, filed Jan. 3, 2003, titled “Anti-Inflammatory Humate Compositions and Methods of Use Thereof”, issued as U.S. Pat. No. ______ on ______.FIELD OF THE INVENTION [0002] The present invention relates to anti-inflammatory humate compositions and their methods of use. In particular, it relates to humate compositions containing natural humate and other anti-inflammatory chemicals. It additionally relates to the use of humate in treating inflammation either alone or in combination with other anti-inflammatory chemicals. BACKGROUND OF THE INVENTION [0003] Chemical studies of the composition of humates such as Menefee Humate® and leonardite have revealed that they are mainly composed of the mixed salts of acid radicals found in soil humus, a product of the decay of organic matter that contains both humic and nonhumic material. Such acid radicals are collectively...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K36/18A61K31/405A61K36/10
CPCY10S514/866A61K31/405
Inventor LOWN, JOHN F.GILL, KEVINCUTLER, STEPHEN J.CUTLER, HORACE G.POLLOCK, STANLEY H.
Owner TBNI